Literature DB >> 9237125

Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro.

R Korpela1, E Moilanen, M Saxelin, H Vapaatalo.   

Abstract

Lactobacillus rhamnosus GG is an experimentally and clinically well documented probiotic used in different dairy products. The present study aimed to investigate the safety aspects of Lactobacillus rhamnosus GG, particularly with respect to platelet aggregation, the initiating event in thrombosis. Platelet rich plasma was separated from the blood of healthy volunteers, and the effects of Lactobacillus rhamnosus GG (ATCC 53103), Lactobacillus rhamnosus (ATCC 7469) and Enterococcus faecium T2L6 in different dilutions on spontaneous, ADP- and adrenaline-induced aggregation were tested. The bacteria did not influence spontaneous aggregation. Only Enterococcus faecium T2L6 enhanced the adrenaline-induced aggregation, with a less clear effect on ADP-induced aggregation.

Entities:  

Mesh:

Year:  1997        PMID: 9237125     DOI: 10.1016/s0168-1605(97)00049-4

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  3 in total

1.  In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.

Authors:  P V Kirjavainen; E M Tuomola; R G Crittenden; A C Ouwehand; D W Harty; L F Morris; H Rautelin; M J Playne; D C Donohue; S J Salminen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Authors:  Eija Nissilä; François P Douillard; Jarmo Ritari; Lars Paulin; Hanna M Järvinen; Pia Rasinkangas; Karita Haapasalo; Seppo Meri; Hanna Jarva; Willem M de Vos
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

3.  Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations.

Authors:  Lidia Stasiak-Różańska; Anna Berthold-Pluta; Antoni Stanisław Pluta; Krzysztof Dasiewicz; Monika Garbowska
Journal:  Int J Environ Res Public Health       Date:  2021-01-27       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.